YAZGAN, S. C. Et Al. 2022. Prognostic role of pan-immune-inflammation value in patients with metastatic castration-resistant prostate cancer treated with androgen receptor-signaling inhibitors. PROSTATE , vol.82, no.15 , 1456-1461.

YAZGAN, S. C., Yekeduz, E., UTKAN, G., & ÜRÜN, Y., (2022). Prognostic role of pan-immune-inflammation value in patients with metastatic castration-resistant prostate cancer treated with androgen receptor-signaling inhibitors. PROSTATE , vol.82, no.15, 1456-1461.

YAZGAN, SATI Et Al. "Prognostic role of pan-immune-inflammation value in patients with metastatic castration-resistant prostate cancer treated with androgen receptor-signaling inhibitors," PROSTATE , vol.82, no.15, 1456-1461, 2022

YAZGAN, SATI C. Et Al. "Prognostic role of pan-immune-inflammation value in patients with metastatic castration-resistant prostate cancer treated with androgen receptor-signaling inhibitors." PROSTATE , vol.82, no.15, pp.1456-1461, 2022

YAZGAN, S. C. Et Al. (2022) . "Prognostic role of pan-immune-inflammation value in patients with metastatic castration-resistant prostate cancer treated with androgen receptor-signaling inhibitors." PROSTATE , vol.82, no.15, pp.1456-1461.

@article{article, author={SATI COŞKUN YAZGAN Et Al. }, title={Prognostic role of pan-immune-inflammation value in patients with metastatic castration-resistant prostate cancer treated with androgen receptor-signaling inhibitors}, journal={PROSTATE}, year=2022, pages={1456-1461} }